FIL Ltd - VANECK VECTORS ETF TR ownership

VANECK VECTORS ETF TR's ticker is GDX and the CUSIP is 92189F106. A total of 703 filers reported holding VANECK VECTORS ETF TR in Q3 2023. The put-call ratio across all filers is 0.70 and the average weighting 0.4%.

Quarter-by-quarter ownership
FIL Ltd ownership history of VANECK VECTORS ETF TR
ValueSharesWeighting
Q3 2023$21,921,935
-10.0%
814,639
+0.7%
0.03%
-3.7%
Q2 2023$24,348,753
+20336.2%
808,660
+21856.6%
0.03%
Q1 2023$119,145
+18.9%
3,683
+5.3%
0.00%
Q4 2022$100,195
-4.6%
3,496
-19.6%
0.00%
Q3 2022$105,000
-21.6%
4,346
-11.2%
0.00%
Q2 2022$134,000
-33.3%
4,896
-6.5%
0.00%
Q1 2022$201,000
-96.0%
5,239
-96.6%
0.00%
-100.0%
Q4 2021$5,003,000
+7.4%
156,183
-1.2%
0.01%0.0%
Q3 2021$4,657,000
+44.5%
158,034
+66.6%
0.01%
+66.7%
Q2 2021$3,223,000
+453.8%
94,832
+430.1%
0.00%
+200.0%
Q1 2021$582,000
-10.3%
17,890
-0.7%
0.00%0.0%
Q4 2020$649,000
-34.1%
18,023
-28.3%
0.00%0.0%
Q3 2020$985,000
-29.4%
25,138
-34.0%
0.00%
-50.0%
Q2 2020$1,396,000
-95.6%
38,071
-97.2%
0.00%
-96.2%
Q1 2020$31,669,000
-4.1%
1,374,497
+21.9%
0.05%
+13.0%
Q4 2019$33,019,000
+23.8%
1,127,713
+13.0%
0.05%
+15.0%
Q3 2019$26,663,000
+47.9%
998,258
+41.6%
0.04%
+48.1%
Q2 2019$18,023,000
+93.2%
705,130
+69.4%
0.03%
+80.0%
Q1 2019$9,331,000
+42.7%
416,172
+34.2%
0.02%
+25.0%
Q4 2018$6,539,000310,0630.01%
Other shareholders
VANECK VECTORS ETF TR shareholders Q3 2023
NameSharesValueWeighting ↓
Memorial Sloan Kettering Cancer Center 738,500$19,873,03580.92%
New Harbor Financial Group, LLC 1,680,752$45,229,03314.96%
TORQ CAPITAL MANAGEMENT (HK) Ltd 139,000$3,740,4909.95%
Vanderbilt University 1,360,540$36,612,1319.45%
Eschler Asset Management LLP 300,000$8,073,0009.42%
New Harbor Financial Group, LLC 1,027,300$27,644,6439.15%
Guild Investment Management, Inc. 139,333$3,749,4546.28%
Monaco Asset Management SAM 750,000$20,182,5005.98%
STRATEGIC INVESTMENT MANAGEMENT, LLC 132,460$3,867,8324.74%
PCG Wealth Advisors, LLC 264,614$7,120,7824.67%
View complete list of VANECK VECTORS ETF TR shareholders